Lincz Lisa F, Mudge Lisa-Maree, Scorgie Fiona E, Sakoff Jennette A, Hamilton Christopher S, Seldon Michael
Department of Haematology, Calvary Mater Newcastle, Newcastle, NSW, Australia.
Neoplasia. 2008 Oct;10(10):1131-7. doi: 10.1593/neo.08644.
Telomerase activity is primarily determined by transcriptional regulation of the catalytic subunit, human telomerase reverse transcriptase (hTERT). Several mRNA splice variants for hTERT have been identified, but it is not clear if telomerase activity is determined by the absolute or relative levels of full-length (functional) and variant hTERT transcripts. We have developed an SYBR green-based reverse transcription-quantitative polymerase chain reaction assay for the enumeration of the four common hTERT mRNA variants and correlated these with telomerase activity and telomere length in 24 human melanoma cell lines. All except five of the lines expressed four hTERT transcripts, with an overall significant level of co-occurrence between absolute mRNA levels of full-length alpha+/beta+ hTERT and the three splice variants alpha-/beta+, alpha+/beta-, and alpha-/beta-. On average, alpha+/beta+ made up the majority (48.1%) of transcripts, followed by alpha+/beta- (44.6%), alpha-/beta- (4.4%), and alpha-/beta+ (2.9%). Telomerase activity ranged from 1 to 247 relative telomerase activity and correlated most strongly with the absolute amount of alpha+/beta+ (R = 0.791, P = .000004) and the relative amount of alpha+/beta- (R = -0.465, P = .022). This study shows that telomerase activity in melanoma cells is best determined by the absolute expression of full-length hTERT mRNA and indicates a role for the hTERT beta deletion variant in the negative regulation of enzyme activity.
端粒酶活性主要由催化亚基人端粒酶逆转录酶(hTERT)的转录调控决定。已鉴定出几种hTERT的mRNA剪接变体,但尚不清楚端粒酶活性是由全长(功能性)和变体hTERT转录本的绝对水平还是相对水平决定。我们开发了一种基于SYBR Green的逆转录定量聚合酶链反应检测方法,用于计数四种常见的hTERT mRNA变体,并将其与24个人黑色素瘤细胞系中的端粒酶活性和端粒长度相关联。除5个细胞系外,所有细胞系均表达四种hTERT转录本,全长α+/β+ hTERT的绝对mRNA水平与三种剪接变体α-/β+、α+/β-和α-/β-之间总体存在显著的共现水平。平均而言,α+/β+占转录本的大多数(48.1%),其次是α+/β-(44.6%)、α-/β-(4.4%)和α-/β+(2.9%)。端粒酶活性范围为1至247相对端粒酶活性,与α+/β+的绝对量(R = 0.791,P = 0.000004)和α+/β-的相对量(R = -0.465,P = 0.022)相关性最强。这项研究表明,黑色素瘤细胞中的端粒酶活性最好由全长hTERT mRNA的绝对表达来确定,并表明hTERTβ缺失变体在酶活性的负调控中起作用。